AUPH News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$2.23B

Volume

582.51K

Next Earnings

November 3rd

Chart Financials Earnings News About Insider Filings

Lupus Nephritis Market on a Growth Trajectory at a CAGR of 7% During the Forecast Period (2026–2036), as Innovative Therapies Gain Momentum | DelveInsightThe lupus nephritis market is projected to grow at a 7% CAGR through 2036, driven by increasing disease awareness, improved diagnosis, and expanding adoption of targeted therapies. The market was valued at USD 2.1 billion in 2025 across seven major markets. Three therapies have received FDA approval (belimumab, voclosporin, and obinutuzumab), while a robust pipeline of innovative treatments including CAR-T therapies, complement inhibitors, and monoclonal antibodies is expected to transform disease management.GlobeNewswire Inc. · Sep 14, 2026

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing TreatmentsThe SLE and LN market is projected to grow from $2.4 billion in 2024 to $5.9 billion by 2034 (9.6% CAGR), driven by 10 late-stage pipeline drugs offering improved safety and efficacy over current generic treatments. However, growth faces headwinds from biosimilar competition and high treatment costs limiting adoption rates.GlobeNewswire Inc. · Apr 10, 2026

New American College of Rheumatology Guidelines for Lupus Nephritis Recommend Triple Therapy, Highlighting a Shift in Current Treatment Practices, According to Spherix Global InsightsThe American College of Rheumatology has updated its guidelines for treating lupus nephritis, recommending early use of triple therapy (mycophenolate mofetil, glucocorticoids, and either Benlysta or a calcineurin inhibitor). However, current practice often delays initiating triple therapy until initial treatment failure.GlobeNewswire Inc. · Jan 8, 2025

Corporate and Individual Donations Provide Much-Needed Support to Kidney Patients Impacted by Hurricane Helene Through the American Kidney Fund’s Disaster Relief ProgramThe American Kidney Fund's Disaster Relief Program is providing emergency financial assistance to dialysis and recent transplant patients in areas affected by Hurricane Helene. The program has received generous support from various companies and individual donors to help cover expenses related to lost medications, housing, transportation, and personal essentials.GlobeNewswire Inc. · Oct 2, 2024

Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.Zacks Investment Research · Jun 17, 2024

How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%The average of price targets set by Wall Street analysts indicates a potential upside of 96.5% in Aurinia (AUPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.Zacks Investment Research · May 7, 2024

Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue EstimatesAurinia (AUPH) delivered earnings and revenue surprises of 82.35% and 8.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 2, 2024

Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For ThursdayTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Wix.com Ltd. (NASDAQ: WIX) from $146 to $165. Piper Sandler analyst Clarke Jeffries maintained an Overweight rating. Wix.com shares rose 5.9% to close at $132.77 on Thursday. See how other analysts view this stock. Keybanc boosted Analog Devices, Inc. (NASDAQ: ADI) price target from $220 to $230. Keybanc analyst John Vinh maintained an Overweight rating. Analog Devices shares gained 2.3% to close at $193.72 on Wednesday. See how other analysts view this stock. Needham raised the price target for Glaukos Corporation (NYSE: GKOS) from $105 to $108. Needham analyst David Saxon maintained a Buy rating. Glaukos shares rose 0.7% to close at $92.79 on Wednesday. See how other analysts view this stock. TD Cowen raised Wingstop Inc. (NASDAQ: WING) ...Full story available on Benzinga.comBenzinga · Feb 22, 2024

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings. Herbalife posted adjusted earnings of 28 cents per share, missing market estimates of 39 cents per share. The company’s quarterly sales came in at $1.22 billion versus expectations of $1.19 billion. Herbalife shares dipped 35.7% to $7.55 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers JX Luxventure Limited (NASDAQ: JXJT) shares jumped 377% to $6.21 following H1 results. Dunxin Financial Holdings Limited (NYSE: DXF) surged 204% to $1.11 after gaining around 5% on Wednesday. China Natural Resources, Inc. (NASDAQ: CHNR) jumped 143% to $2.68 after gaining around 10% on Wednesday. The Children's Place, Inc. (NASDAQ: PLCE) rose 101% to $29.23. Nano-X Imaging Ltd. (NASDAQ: NNOX) shares climbed 54.7% to $9.84. Nvidia reported a 59,632 share stake in Nano X Imaging. RiskOn International, Inc. (NASDAQ: ROI) gained 54% to $0.1710. SoundHound AI, Inc. (NASDAQ: SOUN) gained 53% to $3.4499. According to data from Benzinga Pro, BlackRock reported a 5.6% passive stake in SoundHound AI after the market close. Traders also appear to be circling a filing from Nvidia in which the company disclosed positions in several companies, including SoundHound AI. Orgenesis Inc. (NASDAQ: ORGS) climbed 30.2% to $0.4362. Orgenesis 10% owner Jacob Safier acquired a total of 365,140 shares at an average price of $0.58. Pegasystems Inc. (NASDAQ: PEGA) jumped 27.8% to $64.84 after the company reported better-than-expected fourth-quarter financial results and issued FY24 EPS and revenue guidance above estimates. JFrog Ltd. (NASDAQ: FROG) shares gained 27% to $47.09 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted EPS and revenue guidance above estimates. Infobird Co., Ltd (NASDAQ: IFBD) rose 26% to $1.1800. American Well Corporation (NASDAQ: AMWL) jumped 25% to $1.39 following quarterly results. Datasea Inc. (NASDAQ: DTSS) gained 25% to $11.24. DataSea announced a $30 million 5G multimodal communication technology service agreement. AppLovin Corporation (NASDAQ: APP) rose 22% to $57.16 after the company reported ...Benzinga · Feb 15, 2024

Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue EstimatesAurinia (AUPH) delivered earnings and revenue surprises of -5.56% and 3.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Feb 15, 2024

AUPHAurinia Pharmaceuticals Inc

AUPH

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any AUPH yet.

Related Tickers

Earnings

Mkt Cap

$2.20B

Volume

582.51K

Next Earnings

November 3rd